Catalyst Pharmaceuticals Inc (CPRX)
15.12
+0.40
(+2.68%)
USD |
NASDAQ |
Apr 24, 16:00
15.12
0.00 (0.00%)
After-Hours: 17:16
Catalyst Pharmaceuticals Cash from Financing (TTM): -10.86M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.86M |
| September 30, 2023 | -7.939M |
| June 30, 2023 | 6.172M |
| March 31, 2023 | 3.394M |
| December 31, 2022 | 1.694M |
| September 30, 2022 | -3.085M |
| June 30, 2022 | -9.167M |
| March 31, 2022 | -9.882M |
| December 31, 2021 | -8.143M |
| September 30, 2021 | -5.591M |
| June 30, 2021 | -2.879M |
| March 31, 2021 | 0.864M |
| December 31, 2020 | 0.702M |
| September 30, 2020 | 1.254M |
| June 30, 2020 | 0.8961M |
| March 31, 2020 | 1.053M |
| December 31, 2019 | 1.116M |
| September 30, 2019 | 0.6895M |
| June 30, 2019 | 0.5379M |
| March 31, 2019 | 0.3494M |
| December 31, 2018 | 0.2931M |
| September 30, 2018 | 54.28M |
| June 30, 2018 | 55.58M |
| March 31, 2018 | 57.38M |
| December 31, 2017 | 57.35M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.294M |
| June 30, 2017 | 1.886M |
| March 31, 2017 | 0.0803M |
| December 31, 2016 | 0.069M |
| September 30, 2016 | 0.0541M |
| June 30, 2016 | 0.9708M |
| March 31, 2016 | 1.084M |
| December 31, 2015 | 37.16M |
| September 30, 2015 | 38.92M |
| June 30, 2015 | 38.00M |
| March 31, 2015 | 64.61M |
| December 31, 2014 | 28.56M |
| September 30, 2014 | 26.93M |
| June 30, 2014 | 44.90M |
| March 31, 2014 | 18.20M |
| December 31, 2013 | 18.18M |
| September 30, 2013 | 23.07M |
| June 30, 2013 | 10.67M |
| March 31, 2013 | 14.58M |
| December 31, 2012 | 14.58M |
| September 30, 2012 | 12.81M |
| June 30, 2012 | 7.252M |
| March 31, 2012 | 3.314M |
| December 31, 2011 | 5.543M |
| September 30, 2011 | 2.229M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-10.86M
Minimum
Dec 2023
6.172M
Maximum
Jun 2023
-2.062M
Average
0.6895M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
| Pfizer Inc | 26.07B |
| Sarepta Therapeutics Inc | 125.00M |
| PTC Therapeutics Inc | 646.40M |
| Corcept Therapeutics Inc | -148.72M |
| Cytokinetics Inc | 221.32M |